Watch all the Transform 2020 sessions on-demand here.
Cogito today announced the close of a $20 million funding round to grow its emotion detection offering that lets health care and insurance companies assess customer service satisfaction.
The $20 million round had participation from New York Life Ventures, Goldman Sachs Ventures, and Salesforce Ventures. A company spokesperson declined to state which investor led the round.
The new funds will be used to expand Cogito’s existing offerings to do things like provide more insights for managers and employees using the startup’s Coaching AI system, offer behavioral coaching, and create new behavior models to predict company outcomes.
Founded in 2007 with support from DARPA, Cogito began by conducting trials with veterans with post traumatic stress disorder (PTSD) at the Walter Reed Army Hospital near Washington D.C. and with mothers with postpartum depression at Boston’s Children Hospital.
June 5th: The AI Audit in NYC
Join us next week in NYC to engage with top executive leaders, delving into strategies for auditing AI models to ensure fairness, optimal performance, and ethical compliance across diverse organizations. Secure your attendance for this exclusive invite-only event.
In December 2018, Cogito launched CompanionMx, a spinoff company dedicated to delivering emotion detection to health care providers that tracks depression, bipolar disease, and anxiety. Since launch, CompanionMx has inked partnerships with Massachusetts General Hospital and the U.S. Department of Veteran Affairs to work on detection of PTSD.
Boston-based Cogito has raised more than $90 million to date and currently has 160 employees.
In related news, Amazon’s Alexa AI team is exploring the use of emotion detection in an initiative spearheaded by chief scientist Rohit Prasad, who previously worked with Cogito at DARPA.
